Cambridge, MA Reader Meetup Today (10/18) at 4:30p ET

Arsalan Arif, Publisher
Follow me on twitter and LinkedIn

In the Cambridge/Boston area this evening? Join well-connected FierceBiotech readers like yourself for a drink at Bambara Restaurant in Cambridge (map) between 4:30-7:00p ET. No RSVP is required, but feel free to give us a heads up by e-mail or twitter and we'll look out for you tonight.

We're in town for FierceBiotech's executive breakfast panel Wednesday morning, featuring Peter Mueller (Vertex Pharmaceuticals), Doug Williams (Biogen Idec), Tom Hughes (Zafgen), Omid Farokhzad (Harvard Medical School) and Stephen Knight (Fidelity Biosciences). John Carroll, our esteemed editor-in-chief, will moderate the discussion.

Thanks for being part of the Fierce community. If you're local, hope to see you either this evening or tomorrow. - Arsalan Arif, Publisher (email | twitter)

Suggested Articles

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.

Novavax has brought new CMC head Machielse to head manufacturing; Rexgenero taps Wagener as CMO; EMA nominates Cooke as new director.

The deal grants Sarepta the exclusive right to use Hansa Biopharma’s imlifidase to eliminate neutralizing antibodies in DMD and LGMD patients.